PharmaSeq

Genomics

Overview

Genetic testing is a market that is growing rapidly and is critical for improving quality of life and helping to reduce the cost of healthcare. The PharmaSeq p-Chip® microtransponder provides a unique platform for performing multiplex genetic testing. This has been demonstrated by the Company through the development of an assay that simultaneously identifies 50 distinct mutations for Cystic Fibrosis.

Links

Publications

  1. Lin X, Flint J, Azaro M, Coradetti T, Kopacka W, Streck D, Wang Z, Dermody J, and Mandecki W (2007) Microtransponder-based multiplex assay for genotyping cystic fibrosis. Clin Chem 53:1372-1376. http://www.clinchem.org/cgi/content/full/53/7/1372